Osivo As Quote - 0MXU | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
UK
LSE
Osivo As (0MXU) Share Price

Osivo As (0MXU)

4.00

0.00

(0.00%)

Closed January 06 10:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

4.00

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

4.00 52 Week Range 4.00

Market Cap

Previous Close

4.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

0.00

Shares Outstanding

104,000

Dividend Yield

-

PE Ratio

3.68

Earnings Per Share (EPS)

1.09

Revenue

17.95M

Net Profit

113k

Sector

Food Crops Grown Under Cover

Industry

Food Crops Grown Under Cover

Website

www.osivo.sk

Headquarters

Zvolen, Svk

Founded

-

Osivo As is listed in the Food Crops Grown Under Cover sector of the London Stock Exchange with ticker 0MXU. The last closing price for Osivo As was 4.00 €. Over the last year, Osivo As shares have traded in a share price range of 4.00 € to 4.00 €.

Osivo As currently has 104,000 shares outstanding. The market capitalization of Osivo As is 416,000.00 € . Osivo As has a price to earnings ratio (PE ratio) of 3.68.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	4	4	4	0	0	DE
4	0	0	4	4	4	0	0	DE
12	0	0	4	4	4	0	0	DE
26	0	0	4	4	4	0	0	DE
52	0	0	4	4	4	0	0	DE
156	0	0	4	4	4	0	0	DE
260	0	0	4	4	4	0	0	DE

0MXU - Frequently Asked Questions (FAQ)

What is the current Osivo As share price?

The current share price of Osivo As is 4.00 €

How many Osivo As shares are in issue?

Osivo As has 104,000 shares in issue

What is the market cap of Osivo As?

The market capitalisation of Osivo As is EUR 416k

What is the 1 year trading range for Osivo As share price?

Osivo As has traded in the range of 4.00 € to 4.00 € during the past year

What is the PE ratio of Osivo As?

The price to earnings ratio of Osivo As is 3.68

What is the cash to sales ratio of Osivo As?

The cash to sales ratio of Osivo As is 0.02

What is the reporting currency for Osivo As?

Osivo As reports financial results in EUR

What is the latest annual turnover for Osivo As?

The latest annual turnover of Osivo As is EUR 17.95M

What is the latest annual profit for Osivo As?

The latest annual profit of Osivo As is EUR 113k

What is the registered address of Osivo As?

The registered address for Osivo As is KALINCIAKOVA 2391, ZVOLEN, 960 03

What is the Osivo As website address?

The website address for Osivo As is www.osivo.sk

Which industry sector does Osivo As operate in?

Osivo As operates in the FOOD CROPS GROWN UNDER COVER sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	3.25p (103.13%)	12.18M
BORBorders & Southern Petroleum Plc	3.64p (51.04%)	23.81M
NEONeo Energy Metals Plc	0.95p (22.58%)	37.84M
GNIPGenip Plc	32.00p (20.75%)	192.82k
ZIOCZanaga Iron Ore Company Limited	10.50p (19.86%)	2.84M
DGIDg Innovate Plc	0.02p (-20.00%)	298.54M
SNGSynairgen Plc	2.10p (-19.39%)	1.67M
VRSVersarien Plc	0.03p (-18.92%)	103.72M
QEDQuadrise Plc	5.90p (-17.83%)	17.66M
ZENZenith Energy Ltd.	4.90p (-16.24%)	1.48M
SYMESupply@me Capital Plc	0.0042p (12.00%)	1.19B
MSMNMosman Oil And Gas Limited	0.035p (12.90%)	654.48M
TRPTower Resources Plc	0.0395p (0.00%)	570.56M
CPXCap-xx Limited	0.1775p (-2.74%)	379.2M
NTVONativo Resources Plc	0.0019p (-5.00%)	312.89M

Wrangler1

Wrangler1 4 minutes ago

Waste of time. He spoke as usual a lot of big words but said very little. the stock tomorrow will not move just as I predicted. complete nonsense.

Hello Newman

Hello Newman 4 minutes ago

Whatever happened to Pharma Sleuth?

PennMilitia

PennMilitia 4 minutes ago

Brad there is no recap here

For your information the GOVT wants to monetize their holdings in these companies - whether they are able to do that or not is still in question. Furthermore it has nothing to do with a recap - your out in left field with that one.

Also forg

RKMKE

RKMKE 4 minutes ago

What was exciting in this podcast and i can see nothing in the future as well...Just my opinion..

go seek

go seek 5 minutes ago

DD, you probably have enough shares to initiate a takeover! 😉

boi568

boi568 5 minutes ago

There's every chance that Anavex will be seeking an FDA approval based on the regular schedule rather than accelerated approval. This new draft guidance is another step in the direction the FDA had already been signaling for the use of surrogate endpoints, and is not a surprise either to us or to th

Investor2014

Investor2014 6 minutes ago

I never have and never will short any stock.

Flobewan

Flobewan 6 minutes ago

I'll put the bite right on those libtards
https://investorshub.advfn.com/uimage/uploads/2025/1/6/xqwyuPeanut_MAGA_Hat_6_Jan_2026_(Small).jpg

Slim6

Slim6 7 minutes ago

Wow, 500 million shares have been diluted to over 650 million shares. This company would be bk if they didn't dupe more bagholders to support their continued losses. RBLX is looking worse than ever, increasing losses to over $1 billion per year. Tangible book value is already 0.

LexTrader

LexTrader 7 minutes ago

Regulations are going to be overturned. Get it?

Smartypants2

Smartypants2 7 minutes ago

It may seem like they haven't had their ducks in a row. But that may not be the only explanation. Sometimes slow and steady wins the race -- although it can drive retail investors crazy. The way I look at it, XERI is taking a very deliberate (if not agonizingly slow) approach to the research & devel

aBeezlee

aBeezlee 8 minutes ago

The spectrum could have a lot of value long term, but as of today not going to do much for sp I think. Not until its purpose is announced. Like will it be for Google, DoD etc.

PEACHMAN

PEACHMAN 8 minutes ago

Kitty,there is never any excuse for telling lies about IFUS

You know the pps of IFUS will continue to rise as revenues and sales increase in 2025 and 2026.

New IFUS shareholders should do their own due diligence and ignore paid bashers.

just sayin

rbl100

rbl100 8 minutes ago

What made this jump ? I see no reason for it.

3jack

3jack 8 minutes ago

You should do some major shorting of this stock, if that’s what you truly believe.

Richie Rich

Richie Rich 8 minutes ago

I"ve been calling the office number and no one answers. I've called on different days.

Lime Time

Lime Time 8 minutes ago

More like .02 to .20

Konaploinks

Konaploinks 9 minutes ago

Soon 50. anything will be a gift. I said this at 10. 20. 30. and 40. Way more to come. I’d like to see a 2 for 1 forward split at 100.00. What you guys think?

Gmenfan

Gmenfan 9 minutes ago

Carville, like most Democrats, deludes himself about why Democrats lost the election

By Jack Hellner

James Carville said the Democrats would have won the election in a landslide if they would have disposed of Biden a year earlier.

According to The Hill:

threewheeler

threewheeler 9 minutes ago

KRTL about to launch big time KRTLBIOTECH OTC:KRTL
@KRTLBiotech
“Congratulations $KRTL shareholders: We have successfully completed an acquisition and finalized a joint venture, both with FDA-registered manufacturers. Official press releases will be issued later this week. More to come

Drugdoctor

Drugdoctor 9 minutes ago

You mean back to .02 like $WNFT very soon... Thanks for the confidence.

Gmenfan

Gmenfan 9 minutes ago

Carville, like most Democrats, deludes himself about why Democrats lost the election

By Jack Hellner

James Carville said the Democrats would have won the election in a landslide if they would have disposed of Biden a year earlier.

According to The Hill:

Investor2014

Investor2014 10 minutes ago

You again serve up a complete non sequitur reply.

threewheeler

threewheeler 10 minutes ago

KRTL about to launch big time KRTLBIOTECH OTC:KRTL
@KRTLBiotech
“Congratulations $KRTL shareholders: We have successfully completed an acquisition and finalized a joint venture, both with FDA-registered manufacturers. Official press releases will be issued later this week. More to come

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions